Fig. 4From: Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURNAdjusted hazard ratios for Crohn’s disease-related surgery. CCI, Charlson Comorbidity Index; CD, Crohn’s disease; CI, confidence intervalBack to article page